|
Cilostazol Clinical Trials
4 actively recruiting trials across 2 locations
No change since May 2026
Also known as: Cilostan CR Tab. 200mg, Pletal
Pipeline
Phase 2: 1Phase 4: 1Phase 1/2: 2
Top Sponsors
- Tanta University1
- Seoul National University Bundang Hospital1
- National Institute of Allergy and Infectious Diseases (NIAID)1
- Emory University1
Indications
- Liver Disease1
- Fatty Liver1
- Vulvar Carcinoma1
- Malignant Uterine Neoplasm1
- Primary Peritoneal Carcinoma1
Other2 trials
Atlanta, Georgia1 trial
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
Emory University Hospital Midtown
Phase 2
Bethesda, Maryland1 trial
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
National Institutes of Health Clinical Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.